ZEO vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

ZEO

28.7
AI Score
VS
NIVF Wins

NIVF

50.4
AI Score

Investment Advisor Scores

ZEO

29score
Recommendation
AVOID NEW MONEY

NIVF

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ZEO NIVF Winner
Forward P/E 0 0.0071 Tie
PEG Ratio 0 0 Tie
Revenue Growth -10.7% 11.9% NIVF
Earnings Growth -95.8% 0.0% NIVF
Tradestie Score 28.7/100 50.4/100 NIVF
Profit Margin -15.4% 209.0% NIVF
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD NIVF

Relative Price Performance (Last 90 Days)

ZEO 1M: +30.4% · 3M: -53.5% NIVF 1M: -89.3% · 3M: -91.3%

Current Technical Phase

ZEO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -23.3%), weak momentum, RSI 44

RSI (14): 43.5 · Price: $0.29

NIVF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -19.7%), weak momentum, RSI 31

RSI (14): 31.2 · Price: $0.13

Fundamentals Snapshot

Metric ZEO NIVF
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E — 0.0
Revenue (TTM) — —
Revenue Growth -0.1% 0.1%
Gross Margin 0.5% 0.2%
Operating Margin -0.2% -3.5%
EPS -0.27 197.38
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NIVF is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.